000 01380cam a22003372 b4500
001 11838673
003 US-DLC
005 20161031122315.0
006 m d
007 cr n
008 150615e20160223nyu s|||||||| 2|eng|d
020 _a9780231159753
020 _z0231159757 (Trade Paper)
_cUSD 23.00 Retail Price (Publisher)
024 3 _a9780231159753
035 _a(WaSeSS)ssib023374117
037 _b00006325
040 _aBIP US
_dWaSeSS
_c8/
050 4 _aRA427.25
_b.D53 2016
100 1 _aDickenson, Donna
_eAuthor
210 1 0 _aMe Medicine vs. We Medicine
245 1 0 _aMe Medicine vs. We Medicine
_h[electronic resource]:
_bReclaiming Biotechnology for the Common Good
260 _aNew York :
_bColumbia University Press
_cFeb. 2016
506 _aLicense restrictions may limit access.
520 8 _aAnnotation
_bDonna Dickenson examines the economic and political factors fueling the personalised-medicine phenomenon and explores how, over time, this paradigm shift in how we approach our health might damage our individual and collective well-being.
521 _aScholarly & Professional
_bColumbia University Press
521 2 _a17
_bColumbia University Press
655 0 _2local
_94
_aPrint books.
942 _2lcc
_cBOOKS
049 _aAlfaisal Main Library
264 _aNew York :
_bColumbia University Press
_cFeb. 2016
999 _c312480
_d312480